E3 ubiquitin ligase MAGI3 degrades c-Myc and acts as a predictor for chemotherapy response in colorectal cancer

Haibo Wang(The Third People's Hospital of Dalian City), Junqi He(Qingdao University), Xuedi Cao(Capital Medical University), Hua Liu(China Pharmaceutical University), Zhongtao Zhang(Capital Medical University), Duiping Feng(Shanxi Medical University), Xiaomei Yang(Shanghai Jiao Tong University), Wenjing Yang(Capital Medical University), Ying Yang(Guiyang Medical University), Qiong Qin(Capital Medical University), Siyu Gu(Capital Medical University), Wenxiu Lu(Capital Medical University)
Molecular Cancer
July 22, 2022
10.1186/s12943-022-01622-9
Cited by 70

Related Papers

Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix
|Stem Cell Research & Therapy|2017|462
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
Generation of Endoderm-Derived Human Induced Pluripotent Stem Cells From Primary Hepatocytes
|Hepatology|2010|255
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial
|The Lancet Oncology|2021|184
Dual regulatory switch through interactions of Tcf7l2/Tcf4 with stage-specific partners propels oligodendroglial maturation
|Nature Communications|2016|166